Gene characteristics and changing trend of neonatal thalassemia in Dongguan, China
ZHONG Yu-Hang, YE Li-Xin, CAI Xiao-Juan, XIE Cai-Lian, CHEN Jin-Guo
Dongguan Maternal and Child Health Care Hospital, South Medical University, Dongguan Neonatal Disease Screening Center, Dongguan, Guangdong 523000, China
Abstract Objective To study the gene distribution characteristics of neonatal thalassemia in Dongguan, China and the changing trend of the gene distribution characteristics of neonates with thalassemia in Dongguan in 2014-2018. Methods A retrospective analysis was performed for the data on neonatal thalassemia screening from the Dongguan Neonatal Disease Screening System between January 2014 and December 2018. A total of 616 718 neonates were enrolled who were born in Dongguan. Results Among the 616 718 neonates, 52 308 were positive for primary screening, 10 366 were recalled, 8 576 underwent genetic diagnosis, and 6 432 were confirmed with thalassemia by genetic diagnosis. The carrying rates of thalassemia genes in 2014-2018 were 5.81%, 5.47%, 5.96%, 6.91%, and 7.90% respectively, and showed an upward trend (P < 0.001). The positive rates of neonatal thalassemia screening in 2014-2018 were 9.12%, 8.34%, 7.54%, 8.13%, and 9.32% respectively (P < 0.001). The positive rates of genetic diagnosis of neonatal thalassemia in 2014-2018 were 0.89%, 1.11%, 1.24%, 0.90%, and 1.09% respectively (P < 0.001). In 2014-2018, 5 098 cases of α-thalassemia were detected, accounting for 79.26% of all cases, and 1 230 cases of β-thalassemia were detected, accounting for 19.12% of all cases. The detection rate of α-thalassemia was significantly higher than that of β-thalassemia in each year (P < 0.001). In 2014-2018, static α-thalassemia, mild α-thalassemia, and mild β-thalassemia were the main types observed in neonates. Conclusions Most of the neonates with thalassemia have α-thalassemia in Dongguan, with static α-thalassemia and mild α-thalassemia as the main types. The carrying rate of thalassemia genes keeps increasing in neonates in Dongguan, and the prevention and treatment of thalassemia is still challenging.
Goss C, Giardina P, Degtyaryova D, et al. Red blood cell transfusions for thalassemia:results of a survey assessing current practice and proposal of evidence-based guidelines[J].Transfusion, 2014, 54(7):1773-1781.
Papadea C, Eckman JR, Kuehnert RS, et al. Comparison of liquid and dried blood for neonatal hemoglobinopathy screening:laboratory and programmatic issues[J]. Pediatrics, 1994, 93(3):427-432.
Sirachainan N, Chuansumrit A, Kadegasem P, et al. Normal hemostatic parameters in children and young adults with α-thalassemia diseases[J]. Thromb Res, 2016, 146:35-42.
Xu XM, Zhou YQ, Luo GX, et al. The prevalence and spectrum of alpha and beta thalassaemia in Guangdong Province:implications for the future health burden and population screening[J]. J Clin Pathol, 2004, 57(5):517-522.
